X0306 4 2013-03-18 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001238403 SPIEGELMAN DANIEL K 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2013-03-18 2013-03-18 4 A 0 7 61.4829 A 68683 D Common Stock 2013-03-18 2013-03-18 4 A 0 7 61.3814 A 68690 D Common Stock 2013-03-20 2013-03-20 4 A 0 5 61.9880 A 68695 D Common Stock 2013-03-20 2013-03-20 4 A 0 4 61.4325 A 68699 D Common Stock 2013-06-19 2013-06-19 4 A 0 9 58.5678 A 68708 D Common Stock 2013-06-19 2013-06-19 4 A 0 9 58.8478 A 68717 D Common Stock 2013-09-10 2013-09-10 4 A 0 8 70.0583 A 68725 D Common Stock 2013-09-10 2013-09-10 4 A 0 7 70.3029 A 68732 D Common Stock 2013-10-04 2013-10-04 4 A 0 5 74.0740 A 68737 D Common Stock 2013-10-07 2013-10-07 4 A 0 6 74.8383 A 68743 D Common Stock 2013-10-30 2013-10-30 4 A 0 4 66.4750 A 68747 D Common Stock 2013-10-30 2013-10-30 4 A 0 5 65.7500 A 68752 D Common Stock 2013-11-20 2013-11-20 4 A 0 8 65.8863 A 68760 D Common Stock 2014-03-05 2014-03-05 4 S 0 12 82.9258 D 68748 D Common Stock 2014-05-02 2014-05-02 4 S 0 3 58.0233 D 68745 D Common Stock 2014-05-02 2014-05-02 4 S 0 8 58.7800 D 68737 D Common Stock 2014-08-06 2014-08-06 4 A 0 7 62.1671 A 68744 D Common Stock 2014-08-06 2014-08-06 4 A 0 7 62.1771 A 68751 D Common Stock 2014-09-03 2014-09-03 4 S 0 9 69.8289 D 68742 D Common Stock 2014-09-03 2014-09-03 4 S 0 9 69.7011 D 68733 D Inadvertent transaction not directed by the reporting person through a broker-administered investment pool. Some of the transactions executed as reported herein resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Reporting Person has made arrangements with the Issuer to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions. /s/ Laura Randall Woodhead, Attorney-in-Fact 2015-02-10